(MedPage Today) — It’s the end of the road for Boston Scientific’s Acurate neo2 and Acurate Prime transcatheter aortic valve replacement (TAVR) systems. (Cardiovascular Business)
Self-employed women stood out for having fewer risk factors for…
Source link : https://www.medpagetoday.com/cardiology/prevention/115879
Author :
Publish date : 2025-06-03 17:49:00
Copyright for syndicated content belongs to the linked Source.
